American Capital Advisory’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$565K Buy
2,226
+1,076
+94% +$251K 0.21% 69
2026
Q1
$281K Sell
1,150
-91
-7% -$21.2K 0.11% 89
2025
Q4
$257K Buy
1,241
+14
+1% +$2.77K 0.11% 91
2025
Q3
$228K Buy
1,227
+2
+0.2% +$343 0.11% 95
2025
Q2
$187K Buy
1,225
+27
+2% +$4.15K 0.09% 96
2025
Q1
$199K Buy
1,198
+88
+8% +$13.8K 0.11% 92
2024
Q4
$161K Sell
1,110
-4
-0.4% -$620 0.09% 106
2024
Q3
$181K Buy
1,114
+510
+84% +$81.3K 0.1% 97
2024
Q2
$94.7K Sell
604
-24
-4% -$3.57K 0.07% 120
2024
Q1
$97.4K Buy
628
+24
+4% +$3.82K 0.09% 112
2023
Q4
$94.7K Buy
+604
New +$92.6K 0.07% 120

Other funds holding JNJ

American Capital Advisory's JNJ Position: Q2 2026 in Review

American Capital Advisory increased its Johnson & Johnson (JNJ) stake by 94% in Q2 2026, buying an estimated $251K and bringing the position to 2,226 shares worth $565K. The position accounts for 0.21% of the portfolio, ranked #69.

American Capital Advisory first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • American Capital Advisory held 2,226 shares of Johnson & Johnson worth $565K as of Q2 2026.
  • American Capital Advisory bought 1,076 Johnson & Johnson shares in Q2 2026, an estimated $251K.
  • Johnson & Johnson made up 0.21% of American Capital Advisory's portfolio in Q2 2026, its #69 holding.
  • American Capital Advisory first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.